BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37742483)

  • 21. Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A/B assay: A systematic review and meta-analysis.
    Chang E; Jeon K; Lee N; Park MJ; Song W; Kim HS; Kim HS; Kim JS; Kim J; Jeong S
    J Clin Virol; 2024 Jun; 174():105706. PubMed ID: 38908267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment.
    Heger LA; Elsen N; Rieder M; Gauchel N; Sommerwerck U; Bode C; Duerschmied D; Oette M; Ahrens I
    BMC Infect Dis; 2022 May; 22(1):486. PubMed ID: 35606698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of the real-time PCR cobas
    Young S; Illescas P; Nicasio J; Sickler JJ
    J Clin Virol; 2017 Sep; 94():86-90. PubMed ID: 28772170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Evaluation of Two Automated Multiplex RT-PCR Tests for Rapid Detection of Influenza and Respiratory Syncytial Viruses.
    Hur KH; Sung H; Kim MN
    Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples.
    Akashi Y; Horie M; Kiyotaki J; Takeuchi Y; Togashi K; Adachi Y; Ueda A; Notake S; Nakamura K; Terada N; Kurihara Y; Kiyasu Y; Suzuki H
    Mol Diagn Ther; 2022 May; 26(3):323-331. PubMed ID: 35391608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
    Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
    Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.
    Andrews D; Chetty Y; Cooper BS; Virk M; Glass SK; Letters A; Kelly PA; Sudhanva M; Jeyaratnam D
    BMC Infect Dis; 2017 Oct; 17(1):671. PubMed ID: 29017451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
    Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
    Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-center evaluation of the cobas
    Gibson J; Schechter-Perkins EM; Mitchell P; Mace S; Tian Y; Williams K; Luo R; Yen-Lieberman B
    J Clin Virol; 2017 Oct; 95():5-9. PubMed ID: 28818691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Chiu SK; Wang YH; Liao SJ; Li SY; Hsieh SS; Tsai SH; Perng CL; Yang JR; Liu MT; Chang FY; Shang HS
    Emerg Microbes Infect; 2021 Dec; 10(1):161-166. PubMed ID: 33410371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay.
    Domnich A; Bruzzone B; Trombetta CS; De Pace V; Ricucci V; Varesano S; Garzillo G; Ogliastro M; Orsi A; Icardi G
    J Clin Virol; 2023 Apr; 161():105402. PubMed ID: 36805601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care.
    Mikamo H; Koizumi Y; Yamagishi Y; Asai N; Miyazono Y; Shinbo T; Horie M; Togashi K; Robbins EM; Hirotsu N
    PLoS One; 2022; 17(10):e0276099. PubMed ID: 36301841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2.
    Pattnaik D; Poddar N; Pathi BK; Panigrahi K; Sabat S; Roy A; Patro ARK; Mohapatra A; Patro S; Praharaj AK
    Cureus; 2022 Feb; 14(2):e22470. PubMed ID: 35223334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument.
    Boutin CA; Grandjean-Lapierre S; Gagnon S; Labbé AC; Charest H; Roger M; Coutlée F
    J Clin Virol; 2020 Nov; 132():104615. PubMed ID: 32927356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial prescribing after rapid influenza PCR implementation in the emergency department.
    Wesolowski A; Miller JL; Shields M; Dela-Pena J
    Am J Emerg Med; 2023 Sep; 71():123-128. PubMed ID: 37390608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B.
    Liang LG; Zhu MJ; He R; Shi DR; Luo R; Ji J; Cheng LF; Lu XY; Lu W; Liu FM; Wu ZG; Wu NP; Chen H; Chen Z; Yao HP
    J Med Virol; 2023 Jan; 95(1):e28139. PubMed ID: 36089764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between the analytical sensitivity and clinical performance of two cobas SARS-CoV-2 tests based on high-throughput and point-of-care systems.
    Lin TH; Bui NN; Chang YC; Hsu LY; Su YD; Chang CM; Hong WA; Le UNP; Huang SH; Lin CW
    Biomedicine (Taipei); 2022; 12(2):40-46. PubMed ID: 35836977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Point-of-Care Polymerase Chain Reaction Testing on Prescribing Practices in Primary Care for Management of Strep A: A Retrospective Before-After Study.
    May L; Sickler J; Robbins EM; Tang S; Chugh K; Tran N
    Open Forum Infect Dis; 2022 May; 9(5):ofac147. PubMed ID: 35531385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of Rapid Influenza Molecular Testing in an Outpatient Hemodialysis Unit: A Prospective Cohort Study.
    Kadatz M; Payne M; Kiaii M; Romney MG; Karakas L; Lawson T; Marchuk S; Gill J; Lowe CF
    Can J Kidney Health Dis; 2020; 7():2054358120907816. PubMed ID: 32153798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.